FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition has recombinant clotting factor VIII, polysorbate-80 as a stabilizing agent for prolonged storage and sodium or potassium chloride, calcium salt and L-histidine for system buffering. Method of preparing the claimed composition involves mixing clotting factor VIII with polysorbate-80 and other components or chromatography purification of recombinant clotting factor VIII and its eluting at the last stage of purification with a buffer containing polysorbate-80. Invention relates to also the use of polysorbate-80 as a stabilizing agent of the composition containing recombinant clotting factor VIII. Invention can be used for treatment of patients with hemophilia. EFFECT: stable at storage pharmaceutical composition without an albumiv addition. 22 cl, 2 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
AQUEOUS SOLUTION OF FACTOR VIII AT DECREASED OXYGEN CONCENTRATION | 1994 |
|
RU2142290C1 |
NEW PROTECTIVE COMPOSITIONS FOR RECOMBINANT FACTOR VIII | 2009 |
|
RU2510279C2 |
NEW ALBUMIN-FREE COMPOSITIONS OF FACTOR VIII | 2000 |
|
RU2244556C2 |
STABLE PHARMACEUTICAL COMPOSITION CONTAINING VIII FACTOR | 2003 |
|
RU2314825C2 |
METHOD OF PREPARING FACTOR VIII PREPARATION | 2004 |
|
RU2253475C1 |
STABLE, ALBUMIN-FREE, LYOPHILIZED COMPOSITION OF RECOMBINANT FACTOR VIII | 1997 |
|
RU2201252C2 |
DRY COMPOSITION OF TRANSGLUTAMINE | 2009 |
|
RU2616847C2 |
NOVEL STABILISER FOR PHARMACEUTICAL PROTEINS | 2011 |
|
RU2571496C2 |
NOVEL STABILIZER FOR PHARMACEUTICAL PROTEINS | 2011 |
|
RU2707090C2 |
METHOD OF PRODUCING FACTOR VIII, HAVING IMPROVED RATIO FVIII:C/FVIII:AG | 2015 |
|
RU2695428C2 |
Authors
Dates
1999-09-10—Published
1993-10-01—Filed